Abstract:Juan Jiang, 1 Rongjun Wan, 1 Pinhua Pan, 1 Chengping Hu, 1 Rihua Zhou, 2 Yiping Yin, 2 Ting Zhou, 2 Hua Huang, 2 Yuanyuan Li 1 1 Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan Province, People's Republic of China; 2 Medical Center of Tuberculosis, The Second People's Hospital of Chenzhou, Chenzhou, Hunan Province, People's Republic of China Correspondence: Yuanyuan Li Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, People's Republic of China Tel +86 13975806790 Email leeround@csu.edu.cn Hua Huang Medical Center of Tuberculosis, The Second People's Hospital of Chenzhou, Chenzhou 423000, People's Republic of China Tel +86 18673561888 Email huahua1888@foxmail.com Background: The pandemic of coronavirus disease 2019 (COVID-19) has become a global public health problem. It is important for clinical physicians to differentiate COVID-19 from other respiratory infectious diseases caused by viruses, such as human adenovirus. Subjects and Methods: This was a retrospective observational study. We analyzed and compared the clinical manifestations, laboratory findings and radiological features of two independent cohorts of patients diagnosed with either COVID-19 (n=36) or adenovirus pneumonia (n=18). Results: COVID-19 did not show a preference in males or females, whereas 94.4% of patients with adenovirus pneumonia were males. Fever and cough were common in both COVID-19 and adenovirus pneumonia. But the median maximal body temperature of the adenovirus pneumonia cohort was significantly higher than in COVID-19 ( P < 0.001). Furthermore, 77.8% of patients with adenovirus pneumonia had a productive cough versus only 13.9% of COVID-19 patients ( P < 0.001). Compared with adenovirus pneumonia, constitutional symptoms were less common in COVID-19, including headache (16.7% vs 38.9%, P =0.072), sore throat (8.3% vs 27.8%, P =0.058), myalgia (8.3% vs 61.1%, P < 0.001) and diarrhea (8.3% vs 44.4%, P =0.002). Furthermore, patients with COVID-19 were less likely to develop respiratory failure (8.3% vs 83.3%, P < 0.001) and showed less prominent laboratory abnormalities, including lymphocytopenia (61.1% vs 88.9%, P =0.035), thrombocytopenia (2.8% vs 61.1%, P < 0.001), elevated procalcitonin (2.8% vs 77.8%, P < 0.001) and elevated C-reactive protein (36.1% vs 100%, P < 0.001). Besides, a higher percentage of patients with adenovirus pneumonia showed elevated transaminase, myocardial enzymes, creatinine and D-dimer compared with COVID-19 patients. On chest CT, the COVID-19 cohort was characterized by peripherally distributed ground-glass opacity and patchy shadowing, while the adenovirus pneumonia cohort frequently presented with consolidation and pleural effusion. Conclusion: There were many differences between patients diagnosed with COVID-19 and those with adenovirus pneumonia in their clinical, laboratory and radiological characteristics. Compared with adenovirus pneumonia, COVID-19 patients tended to show a lower severity of illness. Keywords: coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, human adenovirus, adenovirus pneumonia, differential diagnosis

Comparison of Hospitalized Patients with ARDS Caused by COVID-19 and H1N1.

Comparison of the Clinical and CT Features Between COVID-19 and H1N1 Influenza Pneumonia Patients in Zhejiang, China

Comparison of patients with avian influenza A (H7N9) and influenza A (H1N1) complicated by acute respiratory distress syndrome

A comparison of demographic, epidemiological and clinical characteristics of hospital influenza-related viral pneumonia patients

Comparative analysis of elderly hospitalized patients with COVID-19 or influenza A H1N1 virus infections

Comparison of Hospitalized Patients with Pneumonia Caused by COVID-19 and Influenza A in Children under 5 Years.

Mortality in patients with COVID-19 versus non-COVID-19- related acute respiratory distress syndrome: A single center retrospective observational cohort study

Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality

Acute respiratory failure in COVID-19: is it “typical” ARDS?

Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and Acute Respiratory Distress Syndrome

Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.

Comparative study of hematological and radiological feature of severe/critically ill patients with COVID‐19, influenza A H7N9, and H1N1 pneumonia

Retrospective Comparison of Influenza and COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS): An Experience From a Tertiary Care Hospital

Differentiation of COVID‐19 from Seasonal Influenza: A Multicenter Comparative Study

Comparison of Clinical Features and Outcomes between SARS-CoV-2 and Non-SARS-CoV-2 Respiratory Viruses Associated Acute Respiratory Distress Syndrome: Retrospective Analysis

Comparison of Clinical, Laboratory and Radiological Characteristics Between COVID-19 and Adenovirus Pneumonia: A Retrospective Study

Comparison of Clinical Characteristics and Outcomes in Intensive Care Units Between Patients with Coronavirus Disease 2019 (COVID-19) and Patients with Influenza: A Systematic Review and Meta-Analysis

Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia

Differences of respiratory mechanics in mechanical ventilation of acute respiratory distress syndrome between patients with COVID-19 and Influenza A

Comparison of clinical characteristics between COVID-19 and H7N9 fatal cases: An observational study